NCT07826559

Brief Summary

The goal of this clinical trial was to learn if using a brain monitor to adjust anesthesia (sleep medicine) during surgery could prevent emergence delirium (severe confusion and agitation upon waking) in children aged 2 to 12 years having their tonsils or adenoids removed. The main questions it aimed to answer were: Did using a brain monitor lower the chance of children waking up confused and upset? Did using the brain monitor reduce the amount of anesthesia gas (sevoflurane) needed during surgery, and did it affect recovery time or pain levels? Researchers compared anesthesia adjusted using a bispectral index (BIS) brain monitor to anesthesia adjusted using standard care to see if the brain monitor lowered the chance of emergence delirium. Participants in the study: Received general anesthesia (a standardized mix of inhaled and intravenous medicines, including sevoflurane and fentanyl) to safely sleep through surgery to remove their tonsils or adenoids Had the dose of their main anesthesia gas (sevoflurane) adjusted during surgery based on either brain monitor readings (targeting a specific sleep depth of 40-60) or standard physical responses (like heart rate and blood pressure) Were checked by the research team immediately after waking up to measure their confusion, agitation, and pain using standard clinical rating scales

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
125

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 8, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 21, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 21, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 4, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 17, 2026

Completed
Last Updated

September 17, 2026

Status Verified

September 1, 2026

Enrollment Period

4 months

First QC Date

August 4, 2026

Last Update Submit

September 15, 2026

Conditions

Keywords

emergence deliriumpediatric anesthesiabispectral indexanesthetic depthadenoidectomytonsillectomy

Outcome Measures

Primary Outcomes (3)

  • Primary Outcome Measure 1: Incidence of Emergence Delirium Assessed by the PAED Scale

    Evaluated postoperatively using the Pediatric Anesthesia Emergence Delirium (PAED) scale. The scale ranges from a minimum of 0 to a maximum of 20. Higher scores mean a worse outcome (more severe delirium). Scores of 10 or higher were classified as a positive diagnosis for emergence delirium.

    Postoperative minutes 5, 10, 15, 30, 45, and 60 following extubation.

  • Primary Outcome Measure 2: Incidence of Emergence Delirium Assessed by the Watcha Scale

    Evaluated postoperatively using the Watcha behavioral scale. The scale ranges from a minimum of 1 to a maximum of 4. Higher scores mean a worse outcome (greater agitation and delirium). Scores of 3 to 4 were classified as a positive diagnosis for emergence delirium.

    Postoperative minutes 5, 10, 15, 30, 45, and 60 following extubation.

  • Primary Outcome Measure 3: Incidence of Emergence Delirium Assessed by the Cravero Scale

    Evaluated postoperatively using the Cravero behavioral scale. The scale ranges from a minimum of 1 to a maximum of 5. Higher scores mean a worse outcome (greater agitation). Scores of 4 or higher were classified as a positive diagnosis for emergence delirium.

    Postoperative minutes 5, 10, 15, 30, 45, and 60 following extubation.

Secondary Outcomes (4)

  • Total Sevoflurane Consumption

    Intraoperative (From anesthesia induction until the completion of surgery).

  • Postoperative Pain Assessed by the FLACC Scale

    Postoperative minutes 5, 10, 15, 30, 45, and 60 following extubation.

  • Rescue Opioid Usage

    Up to 60 minutes during the post-anesthesia recovery period.

  • Recovery Time

    Up to 4 hours (From transfer to the recovery unit until discharge criteria were successfully met).

Study Arms (2)

BIS-Guided Anesthesia

EXPERIMENTAL

This group received the specific intervention (the BIS monitor to guide anesthesia depth) that is the main focus of your research study.

Device: BIS-Guided Anesthesia

Standard Care Anesthesia

ACTIVE COMPARATOR

This group received the standard, established method of care (titrating anesthesia based on heart rate and blood pressure).

Drug: Standard Care Anesthesia

Interventions

Anesthetic depth was continuously guided by the Bispectral Index (BIS) monitor. A single-use BIS sensor was placed on the patient's forehead before anesthesia induction to record real-time EEG activity. The primary inhaled anesthetic (sevoflurane) was continuously titrated throughout the surgery to strictly maintain a BIS value within the target range of 40 to 60. If the BIS value dropped below 40, the sevoflurane concentration was decreased. If the BIS value exceeded 60, the continuous remifentanil infusion (0.02-0.1 mcg/kg/min) was increased first, followed by an increase in sevoflurane if necessary. Intervention

BIS-Guided Anesthesia

Anesthetic depth was guided solely by traditional clinical signs and autonomic responses. The primary inhaled anesthetic (sevoflurane) was initiated at a 1% end-tidal concentration and adjusted in 0.25% increments (range 0.50% to 1.5%) to maintain the patient's heart rate and blood pressure within ±25% of their baseline pre-anesthesia values. Remifentanil was also infused continuously (0.02-0.1 mcg/kg/min) and adjusted based on clinical requirements. A BIS sensor was attached to the patient to record data, but the monitor screen was completely blinded to the anesthesia care provider, ensuring titration relied exclusively on standard hemodynamic metrics.

Standard Care Anesthesia

Eligibility Criteria

Age2 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children between the ages of 2 and 12 years
  • Scheduled for a planned surgery to remove adenoids, tonsils, or both
  • Generally healthy or having only mild medical conditions (American Society of Anesthesiologists class I or II)
  • Expected to have a surgery that lasts less than 4 hours
  • Having the procedure as an outpatient and expected to go home the same day

You may not qualify if:

  • Having severe medical conditions (American Society of Anesthesiologists class III or IV)
  • Having a known history of neurological or psychiatric diseases
  • Diagnosed with a developmental delay
  • Having severe heart, lung, or metabolic conditions
  • Having a known allergy to any of the medications used in the study
  • Parents or legal guardians refuse to provide written consent to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baskent University

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
This was a single-blind clinical trial. Participants and their guardians were masked to the study arm assignment. Anesthesia care providers could not be masked to the intervention assignment itself, as they were required to actively titrate the anesthesia based on the assigned method. However, a specific masking protocol was used for the active comparator group to prevent bias. In the standard care group, the BIS monitor was applied to the patient to record data, but the screen was completely covered. This ensured the care provider remained masked to the actual BIS values during the surgery, forcing them to rely solely on standard hemodynamic-guided titration.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This study utilized a parallel assignment model. A total of 125 pediatric patients (aged 2 to 12 years) undergoing adenoidectomy and/or tonsillectomy were randomized in a 1:1 ratio into two distinct, simultaneous arms: the intervention group (BIS-guided anesthesia) and the active comparator group (standard care). During the intraoperative phase, both groups received identical anesthetic agents (sevoflurane and remifentanil). The fundamental difference between the parallel arms was the titration strategy. In the BIS arm, sevoflurane was titrated continuously to maintain a strict Bispectral Index target of 40-60. In the standard-care arm, anesthesiologists adjusted the sevoflurane dosage based entirely on traditional clinical and hemodynamic responses, such as heart rate and blood pressure. Participants remained in their initially assigned arms for the entire duration of the surgery and the postoperative recovery observation period. No crossover design was utilized.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2026

First Posted

September 17, 2026

Study Start

August 8, 2025

Primary Completion

November 21, 2025

Study Completion

November 21, 2025

Last Updated

September 17, 2026

Record last verified: 2026-09

Locations